Cargando…
Doxorubicin Induces Inflammatory Modulation and Metabolic Dysregulation in Diabetic Skeletal Muscle
Anti-cancer agent doxorubicin (DOX) has been demonstrated to worsen insulin signaling, engender muscle atrophy, trigger pro-inflammation, and induce a shift to anaerobic glycolytic metabolism in skeletal muscle. The myotoxicity of DOX in diabetic skeletal muscle remains largely unclear. This study e...
Autores principales: | Supriya, Rashmi, Tam, Bjorn T., Pei, Xiao M., Lai, Christopher W., Chan, Lawrence W., Yung, Benjamin Y., Siu, Parco M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961708/ https://www.ncbi.nlm.nih.gov/pubmed/27512375 http://dx.doi.org/10.3389/fphys.2016.00323 |
Ejemplares similares
-
S100A8 and S100A9 Are Associated with Doxorubicin-Induced Cardiotoxicity in the Heart of Diabetic Mice
por: Pei, Xiao M., et al.
Publicado: (2016) -
Protective Effect of Unacylated Ghrelin on Compression-Induced Skeletal Muscle Injury Mediated by SIRT1-Signaling
por: Ugwu, Felix N., et al.
Publicado: (2017) -
SIRT1-dependent myoprotective effects of resveratrol on muscle injury induced by compression
por: Sin, Thomas K., et al.
Publicado: (2015) -
Adipokine Profiling in Adult Women With Central Obesity and Hypertension
por: Supriya, Rashmi, et al.
Publicado: (2018) -
Ablation of Bax and Bak protects skeletal muscle against pressure-induced injury
por: Tam, Bjorn T., et al.
Publicado: (2018)